Convenia

Convenia 80 mg/ml, powder and solvent for injectable solution for dogs and cats

Each 23 ml vial with lyophilized powder contains:

Active substance: 852 mg cefovecin (as sodium salt)

Excipients: 19.17 mg methyl parahydroxybenzoate (E218)

                  2.13 mg propyl parahydroxybenzoate (E216)

Each 19 ml vial with diluent contains:

Excipients: 13 mg/ml benzyl alcohol

                 10.8 ml water for injections

Each 5 ml vial with lyophilized powder contains:

Active substance: 340 mg cefovecin (as sodium salt)

Excipients: 7.67 mg methyl parahydroxybenzoate (E218)

                  0.85 mg propyl parahydroxybenzoate (E216)

Each 10 ml vial with diluent contains:

Excipients: 13 mg/ml benzyl alcohol

                  4.45 ml water for injections

When reconstituted according to the instructions in the leaflet, the injected solution contains:

80.0 mg/ml cefovecin (as sodium salt)

1.8 mg/ml methyl parahydroxybenzoate (E218),

0.2 mg/ml propyl parahydroxybenzoate (E216),

12.3 mg/ml benzyl alcohol.

To be used only in the case of the following infections that require prolonged treatment. After a single administration, the antimicrobial action of the Convenia product lasts up to 14 days.

Dogs:

For the treatment of skin and soft tissue infections including pyoderma, wounds and abscesses associated with Staphylococcus pseudintermedius, Haemolytic Streptococci, Escherichia coli and/or Pasteurella multocida. For the treatment of urinary tract infections associated with Escherichia coli and/or Proteus spp. As adjunctive treatment in mechanical or surgical periodontal therapy, in the treatment of serious infections of the gums and periodontal tissues associated with Porphyromonas spp. and Prevotella spp. (see also Section 4.5 "Special precautions for use").

Cats:

For the treatment of abscesses and wounds of the skin and soft tissues associated with Pasteurella multocida, Fusobacterium spp., Bacteroides spp., Prevotella oralis, β-haemolytic Streptococci, and/or Staphylococcus pseudintermedius. For the treatment of urinary tract infections associated with Escherichia coli.

Skin and soft tissue infections in dogs: A single subcutaneous administration of 8 mg/kg body weight (1 ml per 10 kg body weight). If necessary, the treatment can be repeated after an interval of 14 days, up to three more times. In accordance with good veterinary practice, treatment of pyoderma should be prolonged beyond complete resolution of clinical signs.

Serious infections of the gums and periodontal tissues in dogs: A single subcutaneous administration of 8 mg/kg body weight (1 ml per 10 kg body weight).

Abscesses and wounds of the skin and soft tissues in cats: A single subcutaneous administration of 8 mg/kg body weight (1 ml per 10 kg body weight). If necessary, an additional dose can be administered 14 days after the first administration.

Urinary tract infections in dogs and cats: A single subcutaneous administration of 8 mg/kg body weight (1 ml per 10 kg body weight).

For reconstitution, withdraw the required volume from the diluent vial (for the 23 mL vial containing 852 mg of lyophilized powder reconstituted using 10 mL of diluent or for the 5 mL vial containing 340 mg of lyophilized powder reconstituted using 4 mL of diluent) and add to the vial containing the lyophilized powder. Shake the bottle until the powder is completely dissolved.

Dosage table:

To ensure correct dosing, body weight should be determined as accurately as possible to avoid underdosing.

It does not occur in cases of hypersensitivity to cephalosporin or penicillin antibiotics.

Not for use on small herbivores (including guinea pigs and rabbits).

Do not use for dogs and cats less than 8 weeks old.

Powder: Either 5 ml or 23 ml type I glass vial with a butyl rubber stopper sealed with an aluminum cap.

Diluent: Either 10 ml or 19 ml type I glass vial with a butyl rubber stopper sealed with an aluminum clip.

Package size: 1 vial with powder and 1 vial with diluent. Not all pack sizes may be marketed.

Store in the manufacturer's closed packaging, away from direct sunlight, separate from food and feed, at T°C + 8°C + 25°C

Protect from light.

Shelf life of the veterinary medicinal product as packaged for sale: 3 years. Shelf life after reconstitution according to the indications: 28 days.

As with other cephalosporins, the reconstituted solution may change color during these periods. However, if stored as recommended, effectiveness is not affected.